Overview

Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate

Status:
Active, not recruiting

Trial end date:
2020-08-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to evaluate the effectiveness of ritalin (methylphenidate) taken on an as needed basis for the management of cancer related fatigue. The effects of methylphenidate on pain, mood, and sedation will be evaluated. Researchers will also evaluate the level of fatigue throughout the day and any possible causes of fatigue.

Phase:

Phase 1

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Treatments:

Methylphenidate